Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Molecular Pair Identified as Key to Host-Cell Invasion by Tick-Transmitted Pathogen

By LabMedica International staff writers
Posted on 22 Oct 2012
A pathogen-host “key and door” molecular pair has been identified as critical for the cell-cell adhesion required for invasion by the tick-transmitted pathogen Anaplasma phagocytophilum. More...
The finding provides an important candidate target for development of drugs and a single vaccine against diseases caused by this and closely related pathogens.

A. phagocytophilum is an Anaplasmataceae family bacterium responsible for causing granulocytic anaplasmosis in humans; other tick-transmitted Anaplasmataceae species often cause diseases in domestic and livestock animals, including cattle. From studies in vitro using mammalian cell cultures and in vivo using mice, scientists at the Virginia Commonwealth University (VCU; Richmond, VA, USA) School of Medicine have shown that “outer membrane protein A” (OmpA) on the surface of A. phagocytophilum is critically important for its invasion of host cells. They also delineated a specific region in OmpA that mediates infection and is conserved among Anaplasmataceae family species. The research team showed that OmpA binds mammalian host cell surface sialylated glycoproteins and confirmed that this interaction is important for the adhesion stage of infection. "In other words, we identified both a key and door that together promote Anaplasma phagocytophilum infection," said lead investigator Jason A. Carlyon, PhD, associate professor, and a George and Lavinia Blick Scholar in the Department of Microbiology and Immunology of the VCU School of Medicine. "These findings are important because our data also establish a direction for development of a single vaccine that protects against members of an entire family of bacteria that cause disease," he added.

The study published online and planned to appear in print in the November 2012 issue of the journal Infection and Immunity (volume 80, issue 11), identifies the first A. phagocytophilum adhesin-receptor pair, and delineates the region of OmpA that is critical for infection. Researchers in Prof. Carlyon's laboratory are presently refining their understanding of the molecular basis for how OmpA promotes infection and are testing its efficacy in protecting against infection by A. phagocytophilum and other pathogenenic Anaplasmataceae members.

Related Links:
Virginia Commonwealth University



Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
ESR Analyzer
TEST1 2.0
Automated MALDI-TOF MS System
EXS 3000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.